It’s been seven years in the making but Morpheus is now aiming for real-world application as a pain management tool. Matthew ...
Modern smart collars have evolved from simple GPS trackers to sophisticated biometric instruments capable of early disease ...
Healthcare’s evolution will no longer be defined by hype and venture funding cycles. It will be shaped by a profession ...
The transaction materially strengthens Aclarion’s balance sheet, preserves capital structure integrity, and significantly ...
ShortsIntel announces an AI-powered tool that automates video collection, rights management, and performance analytics, ...
Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...
Chronic rhinosinusitis (CRS) significantly affects ophthalmologic health but remains largely manageable, according to a ...
QuoteIQ, a CRM platform built for mobile and field service businesses, has announced the launch of Route Density, a new ...
To further enhance user experience and accommodate diverse risk preferences and liquidity needs, BenPay DeFi Earn now ...
Aclarion believes the continued expansion of high-quality clinical sites, combined with early surgical throughput, positions CLARITY to progress with increasing efficiency and predictability, ...
News-Medical.Net on MSN
Long COVID symptom clusters that could reshape patient care
A systematic review of Long COVID identifies symptom clusters, highlighting fatigue and proposing a management framework for ...
Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback